BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alavi A, French LE, Davis MD, Brassard A, Kirsner RS. Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment. Am J Clin Dermatol. 2017;18:355-372. [PMID: 28224502 DOI: 10.1007/s40257-017-0251-7] [Cited by in Crossref: 98] [Cited by in F6Publishing: 67] [Article Influence: 32.7] [Reference Citation Analysis]
Number Citing Articles
1 Leiphart PA, Lam CC, Foulke GT. Suppression of pathergy in pyoderma gangrenosum with infliximab allowing for successful tendon debridement. JAAD Case Rep 2018;4:98-100. [PMID: 29379860 DOI: 10.1016/j.jdcr.2017.08.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Tunçez Akyürek F, Akyurek M, Zekey E, Can I, Saylam Kurtipek G. Pyoderma gangrenosum with thymoma and myasthenia gravis: A case report. J Cosmet Dermatol 2021;20:943-6. [PMID: 32920928 DOI: 10.1111/jocd.13717] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhao Y, Fang RY, Feng GD, Cui TT, Gao ZQ. Pyoderma gangrenosum confused with congenital preauricular fistula infection: A case report. World J Clin Cases 2020; 8(9): 1679-1684 [PMID: 32420301 DOI: 10.12998/wjcc.v8.i9.1679] [Reference Citation Analysis]
4 Luo H, Bian H, Sun C, Zheng S, Xiong B, Huang Z, Liu Z, Ma L, Li H, Chen H, Lai W. Pyoderma gangrenosum secondary to caesarean section treated with negative pressure wound therapy and skin graft. Dermatol Ther 2021;34:e14858. [PMID: 33559207 DOI: 10.1111/dth.14858] [Reference Citation Analysis]
5 Mikail M, Wilson A. Low Serum Tumor Necrosis Factor-α Antagonist Concentrations in Patients With Inflammatory Bowel Disease Who Achieve Healing From Pyoderma Gangrenosum. Inflamm Bowel Dis 2021:izab148. [PMID: 34089257 DOI: 10.1093/ibd/izab148] [Reference Citation Analysis]
6 Mella JR, Maselli AM, Guo L. A Deceptive Diagnosis: Pyoderma Gangrenosum After Breast Surgery—A Case Series and Literature Review. Ann Plast Surg 2019;83:S21-30. [DOI: 10.1097/sap.0000000000002101] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Alonso-León T, Hernández-Ramírez HH, Fonte-Avalos V, Toussaint-Caire S, E Vega-Memije M, Lozano-Platonoff A. The great imitator with no diagnostic test: pyoderma gangrenosum. Int Wound J 2020;17:1774-82. [PMID: 32779354 DOI: 10.1111/iwj.13466] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Opalińska A, Kwiatkowska D, Burdacki A, Markiewicz M, Samotij D, Dudziński M, Niemiec-Dudek J, Ostańska E, Reich A. Multifocal Pyoderma Gangrenosum with an Underlying Hemophagocytic Lymphohistiocytosis: Case Report and the Review of the Literature. Dermatol Ther (Heidelb) 2021;11:1217-37. [PMID: 34176093 DOI: 10.1007/s13555-021-00571-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Monari P, Moro R, Motolese A, Misciali C, Baraldi C, Fanti PA, Caccavale S, Puviani M, Olezzi D, Zampieri P, Trevisan G, Nan K, Fiorentini C, Pellacani G, Gualdi G. Epidemiology of pyoderma gangrenosum: Results from an Italian prospective multicentre study. Int Wound J 2018;15:875-9. [PMID: 29877043 DOI: 10.1111/iwj.12939] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
10 Bingoel AS, Krezdorn N, Kaltenborn A, Dastagir K, Jokuszies A, Mett TR, Vogt PM. The surgical approach to Pyoderma gangrenosum: A retrospective monocenter study. Wound Repair Regen 2021;29:478-85. [PMID: 33835625 DOI: 10.1111/wrr.12918] [Reference Citation Analysis]
11 Chen W, Xiang L, Li L. Therapeutic Efficacy of the Combination Therapy of Corticosteroids and 5-Aminosalicylic Acid for Treatment of Pyoderma Gangrenosum with Ulcerative Colitis. Indian J Dermatol 2020;65:38-41. [PMID: 32029938 DOI: 10.4103/ijd.IJD_505_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Nahm WJ, Mota JA, Rojas S, Hizon BJ, Gordon C. Improvement of Ulcerations in Treatment-Resistant Chronic Scarring in a Patient with Pyoderma Gangrenosum After Improving Vascular Insufficiency, Gently Removing Necrotic Debris, and Decreasing Wound Fluid. Am J Case Rep 2018;19:844-8. [PMID: 30022021 DOI: 10.12659/AJCR.908995] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Petty AJ, Whitley MJ, Balaban A, Ellington K, Marano AL. Pyoderma gangrenosum induced by secukinumab in a patient with psoriasis successfully treated with ustekinumab. JAAD Case Rep 2020;6:731-3. [PMID: 32715064 DOI: 10.1016/j.jdcr.2020.06.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Sevimli Dikicier B. Pyoderma Gangrenosum Associated with Sunitinib: A Case Report. Adv Skin Wound Care 2019;32:427-9. [PMID: 31408027 DOI: 10.1097/01.ASW.0000577128.03996.95] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Fletcher J, Alhusayen R, Alavi A. Recent advances in managing and understanding pyoderma gangrenosum. F1000Res 2019;8:F1000 Faculty Rev-2092. [PMID: 31885859 DOI: 10.12688/f1000research.19909.1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
16 Garber A, Regueiro M. Extraintestinal Manifestations of Inflammatory Bowel Disease: Epidemiology, Etiopathogenesis, and Management. Curr Gastroenterol Rep. 2019;21:31. [PMID: 31098819 DOI: 10.1007/s11894-019-0698-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 10.5] [Reference Citation Analysis]
17 Erickson KM, Reese AM, Ortega-Loayza AG. Gap of knowledge in diagnosis of pyoderma gangrenosum in clinical specialties education. Diagnosis (Berl) 2021. [PMID: 33645932 DOI: 10.1515/dx-2020-0153] [Reference Citation Analysis]
18 Xia FD, Liu K, Lockwood S, Butler D, Tsiaras WG, Joyce C, Mostaghimi A. Risk of developing pyoderma gangrenosum after procedures in patients with a known history of pyoderma gangrenosum-A retrospective analysis. J Am Acad Dermatol 2018;78:310-314.e1. [PMID: 28947285 DOI: 10.1016/j.jaad.2017.09.040] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
19 Mansh M, Riskalla M, Maguiness S. Necrotizing Anogenital Ulcer in a Healthy 8-Month-Old Male. JAMA Dermatol 2018;154:1080-1. [PMID: 29799957 DOI: 10.1001/jamadermatol.2018.0287] [Reference Citation Analysis]
20 Cirotteau P, Heron‐mermin D, Dimicoli‐salazar S, Gérard E, Leroy H, Clément L, Beylot‐barry M. Pyoderma gangrenosum misdiagnosed as necrotising fasciitis or a real association between the two? J Eur Acad Dermatol Venereol 2019;33. [DOI: 10.1111/jdv.15585] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Wang B, Liu T, Liu F, He YL. Pyoderma gangrenosum at multiple sites in a post-colostomy ulcerative colitis patient with chronic hepatitis B virus: A case report. Int Wound J 2020;17:187-90. [PMID: 31663272 DOI: 10.1111/iwj.13255] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Li XL, Ma ZG, Huang WH, Chai EQ, Hao YF. Successful treatment of pyoderma gangrenosum with concomitant immunoglobulin A nephropathy: A case report and review of literature. World J Clin Cases 2018; 6(13): 703-706 [PMID: 30430129 DOI: 10.12998/wjcc.v6.i13.703] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Kapoor M, Rossor AM, Laura M, Reilly MM. Clinical Presentation, Diagnosis and Treatment of TTR Amyloidosis. J Neuromuscul Dis. 2019;6:189-199. [PMID: 30829617 DOI: 10.3233/jnd-180371] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
24 Kapoor M, Rossor AM, Jaunmuktane Z, Lunn MPT, Reilly MM. Diagnosis of amyloid neuropathy. Pract Neurol 2019;19:250-8. [DOI: 10.1136/practneurol-2018-002098] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
25 Feitosa MR, Parra RS, Machado VF, Vilar GN, Aquino JC, Rocha JJR, Kotze PG, Féres O. Adjunctive Hyperbaric Oxygen Therapy in Refractory Crohn's Disease: An Observational Study. Gastroenterol Res Pract 2021;2021:6628142. [PMID: 33995526 DOI: 10.1155/2021/6628142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Borda LJ, Jaller JA, Kirsner RS. Absence of donor-site pathergy following fractional autologous full-thickness skin grafting in pyoderma gangrenosum. Br J Dermatol 2019;181:847-8. [PMID: 30947358 DOI: 10.1111/bjd.17987] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Zapata Alvarez J, Patrón Gómez A. Post Reduction Mammaplasty Pyoderma Gangrenosum: An Unusual Presentation of a Misdiagnosed Entity. Cureus 2020;12:e11432. [PMID: 33324515 DOI: 10.7759/cureus.11432] [Reference Citation Analysis]
28 Salem I, Kimak M, Conic R, Bragazzi NL, Watad A, Adawi M, Bridgewood C, Pacifico A, Santus P, Rizzi M, Petrou S, Colombo D, Fiore M, Pigatto PDM, Damiani G. Neutrophilic Dermatoses and Their Implication in Pathophysiology of Asthma and Other Respiratory Comorbidities: A Narrative Review. Biomed Res Int 2019;2019:7315274. [PMID: 31281845 DOI: 10.1155/2019/7315274] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
29 Kraus RF, Gruber MA, Kieninger M. The influence of extracellular tissue on neutrophil function and its possible linkage to inflammatory diseases. Immun Inflamm Dis 2021. [PMID: 34115923 DOI: 10.1002/iid3.472] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 McPhie ML, Kirchhof MG. Pyoderma gangrenosum treated with secukinumab: A case report. SAGE Open Med Case Rep 2020;8:2050313X20940430. [PMID: 32733679 DOI: 10.1177/2050313X20940430] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Haag CK, Bacik L, Latour E, Morse DC, Fett NM, Ortega-loayza AG. Perioperative management of pyoderma gangrenosum. Journal of the American Academy of Dermatology 2020;83:369-74. [DOI: 10.1016/j.jaad.2020.01.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
32 Almeida IR, Coltro PS, Gonçalves HOC, Westin AT, Almeida JB, Lima RVKS, Silva MF, Farina Junior JA. The role of negative pressure wound therapy (NPWT) on the treatment of pyoderma gangrenosum: A systematic review and personal experience. Wound Repair Regen 2021;29:486-94. [PMID: 33772964 DOI: 10.1111/wrr.12910] [Reference Citation Analysis]
33 Nettleton J, Crawford-Smith H, Adimonye A, McMeekin F. Scrotal necrosis and no Fournier's in sight: a rare case of juvenile gangrenous vasculitis. BMJ Case Rep 2019;12:e226530. [PMID: 30796076 DOI: 10.1136/bcr-2018-226530] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Yamasaki K, Yamanaka K, Zhao Y, Iwano S, Takei K, Suzuki K, Yamamoto T. Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Twenty-six-week phase 3 open-label study. J Dermatol 2020;47:1383-90. [PMID: 32804433 DOI: 10.1111/1346-8138.15533] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
35 Niamtu J. Pyoderma Gangrenosum After Facelift and Otoplasty Surgery: Case Presentations and Literature Review. Journal of Oral and Maxillofacial Surgery 2019;77:834-42. [DOI: 10.1016/j.joms.2018.10.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
36 Guimarães ALM, Lourenço SV, Nico MMS. Aphtha Major Perianalis. J Cutan Med Surg 2019;23:105-7. [PMID: 30192651 DOI: 10.1177/1203475418801276] [Reference Citation Analysis]
37 Grado Sanz R, Conde-Montero E, Pérez Jerónimo L, Peral Vázquez A, Recarte Marín L, Galindo Carlos A, Martín Navarro JA. Clinically inactive pyoderma gangrenosum successfully treated with negative pressure therapy and punch grafting. Int Wound J 2020;17:516-8. [PMID: 31898868 DOI: 10.1111/iwj.13303] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
38 Borda LJ, Wong LL, Marzano AV, Ortega-Loayza AG. Extracutaneous involvement of pyoderma gangrenosum. Arch Dermatol Res 2019;311:425-34. [PMID: 30923901 DOI: 10.1007/s00403-019-01912-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 8.5] [Reference Citation Analysis]
39 Foessleitner P, Just U, Kiss H, Farr A. Challenge of diagnosing pyoderma gangrenosum after caesarean section. BMJ Case Rep 2019;12:e230315. [PMID: 31352396 DOI: 10.1136/bcr-2019-230315] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
40 Maglie R, Genovese G, Solimani F, Guglielmo A, Pileri A, Portelli F, Hertl M, Marzano AV, Antiga E. Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review. Am J Clin Dermatol 2020;21:833-54. [PMID: 32813229 DOI: 10.1007/s40257-020-00553-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
41 Comont T, Treiner E, Giraud JT, Fusaro M, Picard C. A Complex Infectious, Inflammatory, and Autoimmune Phenotype Reveals 22q11.2 Deletion Syndrome in an Adult. J Clin Immunol 2021. [PMID: 34373990 DOI: 10.1007/s10875-021-01095-3] [Reference Citation Analysis]
42 Mckenzie F, Arthur M, Ortega-loayza AG. Pyoderma Gangrenosum: What Do We Know Now? Curr Derm Rep 2018;7:147-57. [DOI: 10.1007/s13671-018-0224-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
43 Aboulian A. Ostomy Complications in Crohn's Disease. Clin Colon Rectal Surg 2019;32:314-22. [PMID: 31275079 DOI: 10.1055/s-0039-1683924] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Cammarata E, Giorgione R, Esposto E, Mazzoletti V, Boggio P, Savoia P. Minced Skin Grafting: A Minimally Invasive and Low-Cost Procedure to Treat Pyoderma Gangrenosum. Adv Skin Wound Care 2021;34:1-3. [PMID: 33443919 DOI: 10.1097/01.ASW.0000725172.24316.fd] [Reference Citation Analysis]
45 Janowska A, Oranges T, Fissi A, Davini G, Romanelli M, Dini V. PG-TIME: A practical approach to the clinical management of pyoderma gangrenosum. Dermatol Ther 2020;33:e13412. [PMID: 32291879 DOI: 10.1111/dth.13412] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
46 Haag CK, Nutan F, Cyrus JW, Satpathy J, Shinkai K, Ortega Loayza AG. Pyoderma gangrenosum misdiagnosis resulting in amputation: A review. J Trauma Acute Care Surg 2019;86:307-13. [DOI: 10.1097/ta.0000000000002096] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
47 O'Connor C, Gallagher C, Hollywood A, Paul L, O'Connell M. Anakinra for recalcitrant pyoderma gangrenosum. Clin Exp Dermatol 2021. [PMID: 34137070 DOI: 10.1111/ced.14809] [Reference Citation Analysis]
48 Billings SD. Common and critical inflammatory dermatoses every pathologist should know. Mod Pathol 2020;33:107-17. [PMID: 31676787 DOI: 10.1038/s41379-019-0400-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Alavi A, Shavit E, Archer J, Pagnoux C. Hidradenitis suppurativa and vasculitis: A case series and literature review of a rare association. SAGE Open Med Case Rep 2019;7:2050313X19882852. [PMID: 31673357 DOI: 10.1177/2050313X19882852] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Shavit E, Cecchini M, Limacher JJ, Walsh S, Wentworth A, Davis MDP, Alavi A. Superficial Granulomatous Pyoderma Gangrenosum Involving the Face: A Case Series of Five Patients and a Review of the Literature [Formula: see text]. J Cutan Med Surg 2021;25:371-6. [PMID: 33541119 DOI: 10.1177/1203475420988864] [Reference Citation Analysis]
51 Liu FC, Liu NT, Huang TY. Ulcerative colitis with refractory pyoderma gangrenosum. QJM 2020;113:567-8. [PMID: 32129869 DOI: 10.1093/qjmed/hcaa078] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
52 Saternus R, Schwingel J, Müller CSL, Vogt T, Reichrath J. Ancient friends, revisited: Systematic review and case report of pyoderma gangrenosum-associated autoinflammatory syndromes. J Transl Autoimmun 2020;3:100071. [PMID: 33305249 DOI: 10.1016/j.jtauto.2020.100071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
53 Rongisch R, Koll P, Eming SA. [Targeted therapies in Pyoderma gangrenosum: deciphering pathophysiology and improving disease management]. Hautarzt 2020;71:880-6. [PMID: 32997216 DOI: 10.1007/s00105-020-04697-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Marzano AV, Borghi A, Wallach D, Cugno M. A Comprehensive Review of Neutrophilic Diseases. Clinic Rev Allerg Immunol 2018;54:114-30. [DOI: 10.1007/s12016-017-8621-8] [Cited by in Crossref: 63] [Cited by in F6Publishing: 45] [Article Influence: 15.8] [Reference Citation Analysis]
55 Oz RS, Onajin O, Harel L, Tal R, Dallos T, Rosenblatt A, Plank L, Wagner-Weiner L. Pyoderma gangrenosum-like ulceration as a presenting feature of pediatric granulomatosis with polyangiitis. Pediatr Rheumatol Online J 2021;19:81. [PMID: 34090470 DOI: 10.1186/s12969-021-00564-8] [Reference Citation Analysis]
56 Didona D, Fania L, Didona B, Eming R, Hertl M, Di Zenzo G. Paraneoplastic Dermatoses: A Brief General Review and an Extensive Analysis of Paraneoplastic Pemphigus and Paraneoplastic Dermatomyositis. Int J Mol Sci 2020;21:E2178. [PMID: 32245283 DOI: 10.3390/ijms21062178] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
57 Reese AM, Haag CK, Jung E, Nauta AC, Swerlick RA, Ortega-loayza AG. Pyoderma gangrenosum underrepresentation in non-dermatological literature. Diagnosis 2021;8:85-90. [DOI: 10.1515/dx-2019-0079] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Maida V, Corban J. Topical Medical Cannabis: A New Treatment for Wound Pain—Three Cases of Pyoderma Gangrenosum. Journal of Pain and Symptom Management 2017;54:732-6. [DOI: 10.1016/j.jpainsymman.2017.06.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
59 Brenner EJ, Long MD. Diagnosis and treatment of dermatologic diseases in inflammatory bowel disease. Curr Opin Gastroenterol 2019;35:330-6. [PMID: 31021924 DOI: 10.1097/MOG.0000000000000538] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
60 Wong LL, Borda LJ, Liem T, Keller JJ, Ortega-Loayza AG, Jung E. Atypical Pyoderma Gangrenosum in the Setting of Venous and Arterial Insufficiency. Int J Low Extrem Wounds 2021;:15347346211002334. [PMID: 33913352 DOI: 10.1177/15347346211002334] [Reference Citation Analysis]
61 Mitrovic S, Fautrel B. Clinical Phenotypes of Adult-Onset Still's Disease: New Insights from Pathophysiology and Literature Findings. J Clin Med 2021;10:2633. [PMID: 34203779 DOI: 10.3390/jcm10122633] [Reference Citation Analysis]
62 Haag CK, Ortega-loayza AG, Latour E, Keller JJ, Fett NM. Clinical factors influencing the response to intravenous immunoglobulin treatment in cases of treatment-resistant pyoderma gangrenosum. Journal of Dermatological Treatment 2020;31:723-6. [DOI: 10.1080/09546634.2019.1606888] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
63 Croitoru D, Naderi-Azad S, Sachdeva M, Piguet V, Alavi A. A Wound Care Specialist's Approach to Pyoderma Gangrenosum. Adv Wound Care (New Rochelle) 2020;9:686-94. [PMID: 32320358 DOI: 10.1089/wound.2020.1168] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
64 Feuerstein JD, Moss AC, Farraye FA. Ulcerative Colitis. Mayo Clin Proc. 2019;94:1357-1373. [PMID: 31272578 DOI: 10.1016/j.mayocp.2019.01.018] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 54.0] [Reference Citation Analysis]
65 Croia C, Dini V, Loggini B, Manni E, Romanelli M, Migliorini P. Evaluation of neutrophil extracellular trap deregulated formation in pyoderma gangrenosum. Exp Dermatol 2021;30:1340-4. [PMID: 34057268 DOI: 10.1111/exd.14397] [Reference Citation Analysis]
66 Fang R, Wang J, Jiang XY, Wang SH, Cheng H, Zhou Q. Case Report: A Novel Mutation in NFKB1 Associated With Pyoderma Gangrenosum. Front Genet 2021;12:673453. [PMID: 34447408 DOI: 10.3389/fgene.2021.673453] [Reference Citation Analysis]
67 Chen ZQ, Huang JF, Ma LL, Zhang CL, Lei S. Usefulness of metagenomic analysis in differential diagnosis for pyoderma gangrenosum. J Int Med Res 2018;46:3468-73. [PMID: 29936877 DOI: 10.1177/0300060518780124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]